|
(PQ12) Peroxisome proliferator-activated receptor alpha agonists as potential treatment for chemotherapy-induced peripheral neuropathy
|
1R01CA219637-01A1
|
$281,441
|
DAMAJ, M IMAD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-04S1
|
$7,505
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-04
|
$334,291
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
|
5R01CA206028-03
|
$342,846
|
GEWIRTZ, DAVID
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-04
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
A microRNA mediating vascular directed fibrinolysis and tumor progression
|
5F31CA213793-03
|
$33,794
|
MCCANN, JAMES
|
UNIVERSITY OF VIRGINIA
|
|
ABT-199 based therapies to treat neuroblastoma
|
5R01CA215610-02
|
$359,846
|
FABER, ANTHONY
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
An integrated systems approach for incompletely penetrant onco-phenotypes
|
3U01CA215794-02S1
|
$71,286
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
An Integrated Systems Approach for Incompletely Penetrant Onco-phenotypes.
|
5U01CA215794-02
|
$445,618
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
Antibodies to melanoma vaccine peptides
|
5R03CA219715-02
|
$80,750
|
SLINGLUFF, CRAIG
|
UNIVERSITY OF VIRGINIA
|
|
Biology of colorectal cancer risk enhancers
|
5R01CA204279-04
|
$453,387
|
CASEY, GRAHAM
|
UNIVERSITY OF VIRGINIA
|
|
Biospecimen procurement and tissue microarray manufacture for the CHTN
|
5UM1CA183712-05
|
$531,453
|
MOSKALUK, CHRISTOPHER
|
UNIVERSITY OF VIRGINIA
|
|
Cancer Research Training in Molecular Biology
|
5T32CA009109-42
|
$517,664
|
BOUTON, AMY
|
UNIVERSITY OF VIRGINIA
|
|
Ceramide Nanoliposomes in Combination with Focused Ultrasound for Treating Breast Cancer
|
1R21CA230088-01
|
$171,520
|
PRICE, RICHARD
|
UNIVERSITY OF VIRGINIA
|
|
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer
|
5R01CA178338-05
|
$327,850
|
GIOELI, DANIEL
|
UNIVERSITY OF VIRGINIA
|
|
cis-splicing of adjacent genes in prostate cancer
|
5R01CA190713-05
|
$327,850
|
LI, HUI
|
UNIVERSITY OF VIRGINIA
|
|
Comprehensive analysis and mitigation of the clinical effects of delineation and geometric uncertainties in conformal radiation therapy
|
1R01CA222216-01A1
|
$363,804
|
SIEBERS, JEFFREY
|
UNIVERSITY OF VIRGINIA
|
|
Computational modeling of tumor burden by CT to advance cancer therapeutics
|
5R01CA194783-04
|
$573,026
|
MAITLAND, MICHAEL
|
INOVA HEALTH CARE SERVICES
|
|
Cytokine induced RelB/p50 complexes drive mesenchymal glioma progression
|
5F30CA200252-03
|
$36,044
|
WATERS, MICHAEL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Cytokine-induced RelB phosphorylation in glioblastoma multiforme
|
5F30CA203447-03
|
$36,044
|
GUPTA, ANGELA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Developing a mobile application for circadian wellness in cancer patients
|
1R43CA236557-01A1
|
$221,237
|
WALCH, OLIVIA
|
ARCASCOPE, LLC
|
|
Development of an MRI-compatible, High-Frequency Irreversible Electroporation (H-FIRE) System for Non-thermal Ablation of Inoperable Brain Tumors
|
1R43CA233158-01
|
$244,498
|
ARENA, CHRISTOPHER
|
VOLTMED, INC.
|
|
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer
|
5U01CA214194-03
|
$432,349
|
SEMMES, OLIVER
|
EASTERN VIRGINIA MEDICAL SCHOOL
|
|
DICER-Dx: The First Liquid Biopsy for Early Detection and Monitoring of DICER1 Syndrome Pediatric Cancers
|
1R43CA228850-01
|
$299,514
|
BRENNEMAN, MARK
|
RESOURCEPATH, LLC
|
|
DNA-specific pattern recognition receptor activation following DNA electroporation
|
5R01CA196796-03
|
$316,169
|
HELLER, LOREE
|
OLD DOMINION UNIVERSITY
|
|
Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer
|
5R01CA192669-04
|
$413,366
|
LARNER, JAMES
|
UNIVERSITY OF VIRGINIA
|
|
DYRK1A signaling in control of cell growth, proliferation and DNA damage repair
|
3R01CA188571-04S1
|
$48,050
|
LITOVCHICK, LARISA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
DYRK1A signaling in control of cell growth, proliferation and DNA damage repair
|
5R01CA188571-04
|
$341,494
|
LITOVCHICK, LARISA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression
|
5R01CA186730-04
|
$359,454
|
HELLER, RICHARD
|
OLD DOMINION UNIVERSITY
|
|
Enabling a new route for the creation of short, diverse peptide libraries through breaking the degeneracy of the genetic code
|
5R03CA216116-02
|
$72,735
|
HARTMAN, MATTHEW
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Engineered precancerous cells and tissues for discovery of lung cancer drivers
|
5R03CA215777-02
|
$80,750
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
Evaluation of image-guided, conformal, high-dose intraoperative radiation therapy (Precision Breast IORT) for early stage breast cancer
|
1R01CA214594-01A1
|
$382,491
|
SHOWALTER, SHAYNA
|
UNIVERSITY OF VIRGINIA
|
|
Exploring factors related to racial disparities in ovarian cancer incidence and survival: the OCWAA consortium
|
5R01CA207260-02
|
$605,285
|
SCHILDKRAUT, JOELLEN
|
UNIVERSITY OF VIRGINIA
|
|
Exploring the Role of Mitochondrial Fission in Pancreatic Tumorigenesis
|
5R01CA200755-03
|
$548,299
|
KASHATUS, DAVID
|
UNIVERSITY OF VIRGINIA
|
|
Extracellular Vesicles in Small Cell Lung Cancer Early Detection
|
5U01CA213330-02
|
$593,585
|
NANA-SINKAM, SERGE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Focused Ultrasound and Multifunctional Nanoparticle Vaccines as Adjuvant Strategies for Cancer Immunotherapy
|
1F99CA234954-01
|
$40,819
|
SHEYBANI, NATASHA
|
UNIVERSITY OF VIRGINIA
|
|
Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross
|
1R01CA221260-01A1
|
$442,176
|
DAMAJ, M IMAD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers
|
1R01CA211574-01A1
|
$703,749
|
SCHILDKRAUT, JOELLEN
|
UNIVERSITY OF VIRGINIA
|
|
Genomic Architecture of LGL Leukemia
|
5R01CA178393-03
|
$609,097
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
Heterogeneous Loss of GDF11 Tumor Suppression in Triple-negative Breast Cancer
|
1R01CA214718-01A1
|
$360,785
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment
|
5R01CA213423-02
|
$359,874
|
DAVALOS, RAFAEL
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
HIV, HERV-K and Human Cancer
|
5R01CA206275-02
|
$524,710
|
HAMMARSKJOLD, MARIE-LOUISE
|
UNIVERSITY OF VIRGINIA
|
|
Host-tumor interactions and cancer relapse after radiation therapy
|
5R01CA175033-05
|
$316,438
|
WANG, XIANG-YANG (SHAWN)
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Hot Spot Analysis of the Breast Cancer Susceptibility Protein
|
1R01CA227261-01
|
$404,307
|
KELLY, DEBORAH
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
|
5R01CA211648-02
|
$432,788
|
ADLI, MAZHAR
|
UNIVERSITY OF VIRGINIA
|
|
Identifying tumor suppressor targets of SIRT6 in lung cancer
|
5R01CA192399-04
|
$393,711
|
MAYO, MARTY
|
UNIVERSITY OF VIRGINIA
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
3U24CA180803-05S1
|
$335,460
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Imaging and Radiation Oncology Core (IROC) Group
|
5U24CA180803-05
|
$8,285,739
|
FOLLOWILL, DAVID
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
|
5R01CA190665-05
|
$337,529
|
ENGELHARD, VICTOR
|
UNIVERSITY OF VIRGINIA
|
|
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
|
5R01CA197111-04
|
$517,432
|
PRICE, RICHARD
|
UNIVERSITY OF VIRGINIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|